Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Venture Partners is a venture capital firm founded in 2010 and headquartered in San Mateo, California. The firm specializes in early to growth-stage investments at the intersection of advanced materials science and convergent technologies—including biology/life sciences/biotech/healthtech—with computation and AI. They provide hands-on support to entrepreneurs across business development, IP strategy, financing/recruitment/exits. Their investment focus includes: Advanced materials, Photonics/electronics/hardware, Clean technology/energy sustainability, Biotechnology/life sciences/healthcare devices. They have invested in over 40–69 companies with notable exits and strategic partnerships (including Pfizer). Their typical check size ranges from $100k up to $25M per deal depending on stage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Venture Partners.